Susquehanna International Group
VYNT

Susquehanna International Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Susquehanna International Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-903
Closed -$366K – 10097
2017
Q3 		$366K Buy
903
+264
+41% +$138K ﹤0.01% 7058
2017
Q2 		$378K Buy
+639
New +$374K ﹤0.01% 7161

Other funds holding VYNT

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group's VYNT Position: Q2 2023 in Review

Susquehanna International Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 20,001 shares — an estimated $11.6K sold.

Susquehanna International Group first reported a position in VYNT in Q1 2014 and held it in 6 quarters. The position peaked at $180K in Q1 2014. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.

  • Susquehanna International Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 20,001 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $11.6K.
  • Susquehanna International Group first reported a position in Vyant Bio, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
  • Susquehanna International Group's Vyant Bio, Inc. Common Stock position peaked at $180K in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.